Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases

Antivascular endothelial growth factor (VEGF) treatment is still used intravitreally worldwide for various neovascular diseases, despite other available, approved treatments. We performed a systematic search of the literature focused on visual physiology studies. We used the online biomedical search...

Full description

Bibliographic Details
Main Authors: In Hwan Hong, Sung Pyo Park
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2017;volume=65;issue=7;spage=559;epage=568;aulast=Hong
_version_ 1818928586277519360
author In Hwan Hong
Sung Pyo Park
author_facet In Hwan Hong
Sung Pyo Park
author_sort In Hwan Hong
collection DOAJ
description Antivascular endothelial growth factor (VEGF) treatment is still used intravitreally worldwide for various neovascular diseases, despite other available, approved treatments. We performed a systematic search of the literature focused on visual physiology studies. We used the online biomedical search engine PubMed and searched key words including “M-chart,” “Preferential Hyperacuity Perimetry,” “microperimetry,” (MP) “electroretinography,” and “contrast sensitivity” to estimate treatment efficacy of anti-VEGF treatments in a quantitative manner. Many studies were identified which used a variety of methodologies, disease entities, injected agents, and patient populations, making it difficult to obtain a direct comparison of their results. However, favorable functional outcomes achieved using current quantitative methods would lend further confidence to the effectiveness of a treat-and-extend protocol using intravitreal anti-VEGF for the management of patients with neovascular diseases. Despite anti-VEGF's wide use, a well-designed longitudinal multicenter study to systematically evaluate and compare different physiological methods or parameters in patients with neovascular diseases is still lacking, though it would benefit therapeutic decisions.
first_indexed 2024-12-20T03:31:16Z
format Article
id doaj.art-2fbf5009a83a42c89e068056099303db
institution Directory Open Access Journal
issn 0301-4738
1998-3689
language English
last_indexed 2024-12-20T03:31:16Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj.art-2fbf5009a83a42c89e068056099303db2022-12-21T19:54:58ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892017-01-0165755956810.4103/ijo.IJO_278_17Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseasesIn Hwan HongSung Pyo ParkAntivascular endothelial growth factor (VEGF) treatment is still used intravitreally worldwide for various neovascular diseases, despite other available, approved treatments. We performed a systematic search of the literature focused on visual physiology studies. We used the online biomedical search engine PubMed and searched key words including “M-chart,” “Preferential Hyperacuity Perimetry,” “microperimetry,” (MP) “electroretinography,” and “contrast sensitivity” to estimate treatment efficacy of anti-VEGF treatments in a quantitative manner. Many studies were identified which used a variety of methodologies, disease entities, injected agents, and patient populations, making it difficult to obtain a direct comparison of their results. However, favorable functional outcomes achieved using current quantitative methods would lend further confidence to the effectiveness of a treat-and-extend protocol using intravitreal anti-VEGF for the management of patients with neovascular diseases. Despite anti-VEGF's wide use, a well-designed longitudinal multicenter study to systematically evaluate and compare different physiological methods or parameters in patients with neovascular diseases is still lacking, though it would benefit therapeutic decisions.http://www.ijo.in/article.asp?issn=0301-4738;year=2017;volume=65;issue=7;spage=559;epage=568;aulast=HongAntivascular endothelial growth factor treatmentmicroperimetry and contrast sensitivityquantitative analysis and electroretinography
spellingShingle In Hwan Hong
Sung Pyo Park
Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
Indian Journal of Ophthalmology
Antivascular endothelial growth factor treatment
microperimetry and contrast sensitivity
quantitative analysis and electroretinography
title Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
title_full Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
title_fullStr Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
title_full_unstemmed Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
title_short Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
title_sort quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
topic Antivascular endothelial growth factor treatment
microperimetry and contrast sensitivity
quantitative analysis and electroretinography
url http://www.ijo.in/article.asp?issn=0301-4738;year=2017;volume=65;issue=7;spage=559;epage=568;aulast=Hong
work_keys_str_mv AT inhwanhong quantitativephysiologicalmeasurementstoevaluatetheresponseofantivascularendothelialgrowthfactortreatmentinpatientswithneovasculardiseases
AT sungpyopark quantitativephysiologicalmeasurementstoevaluatetheresponseofantivascularendothelialgrowthfactortreatmentinpatientswithneovasculardiseases